Found 223 clinical trials
Dupilumab in CRSsNP (Liberty CRSsNP ORION)
Primary Objective: Part A and B: To evaluate the efficacy of dupilumab as assessed by the reduction at Week 24 in sinus opacification on computerized tomography (CT) scan and sinus total symptom score (sTSS) compared to placebo Secondary Objectives: Part A To evaluate the efficacy of dupilumab as assessed by …
- 20 views
- 27 Jan, 2023
- 8 locations
Respiratory Syncytial Virus (RSV)
Reaction (RT-PCR) confirmed Respiratory Syncytial Virus (RSV)-mediated Lower Respiratory Tract Disease (LRTD) when compared to placebo in adults aged 60 years and above.
- 0 views
- 18 Apr, 2022
- 1 location
Respiratory Syncytial Virus (RSV)
Reaction (RT-PCR) confirmed Respiratory Syncytial Virus (RSV)-mediated Lower Respiratory Tract Disease (LRTD) when compared to placebo in adults aged 60 years and above.
- 0 views
- 21 Apr, 2022
- 1 location
Respiratory Syncytial Virus (RSV)
Reaction (RT-PCR) confirmed Respiratory Syncytial Virus (RSV)-mediated Lower Respiratory Tract Disease (LRTD) when compared to placebo in adults aged 60 years and above.
- 0 views
- 14 Jan, 2022
- 1 location
RSV Vaccine for Ages 50-59
of age, including adults at increased risk of respiratory syncytial virus lower respiratory tract disease, compared to older adults ≥60 years of age (RSV OA=ADJ 018)
- 0 views
- 25 Aug, 2022
- 1 location
Double-Blind, Randomized, Placebo-Controlled, Multi-Center Phase 3 Study to Evaluate the Efficacy and Safety of Fostamatinib in COVID-19 Subjects
The primary objective of this study is:To evaluate the efficacy of fostamatinib when used in combination with standard of care (SOC) in subjects hospitalized with COVID-19 without respiratory failure and with certain high risk prognostic factors, as measured by the change in clinical status score.
- 2 views
- 10 Dec, 2021
- 35 locations
Have you been diagnosed with Asthma?
Have you been diagnosed with Asthma?
- 308 views
- 08 Nov, 2020
- 1 location
Do you think you're having difficulty controlling your high blood pressure?
Do you think you're having difficulty controlling your high blood pressure?
- 472 views
- 08 Nov, 2020
- 1 location
A Study to Evaluate the Safety and Efficacy of mRNA-1345 Vaccine Targeting Respiratory Syncytial Virus (RSV) in Adults ≥60 Years of Age
episode of RSV-associated lower respiratory tract disease (RSV-LRTD) as compared with placebo from 14 days postinjection through 12 months.
- 1 views
- 22 Mar, 2022
- 22 locations
A Randomized, Double-blind, Placebo-controlled Phase 3 Study to Evaluate Efficacy, Safety, Reactogenicity, and Immunogenicity of an Ad26.RSV.preF-based Vaccine in Japanese Adults Aged 60 Years and Older, and Safety, Reactogenicity, and Immunogenicity of the Vaccine in Japanese Adults Aged 20 to 59 Years at High-risk of RSV Disease
Tract Disease (LRTD) over one RSV season when compared to placebo in adults aged 60 years and above and to demonstrate the non-inferiority of the vaccine in high-risk adults aged 20 to 59 years versus
- 0 views
- 16 Oct, 2022
- 30 locations